CNE100005Q22
CNE100005Q22
INVENTISBIO CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 10B EUR | 10.43B EUR | 11B EUR | 15.75B EUR |
Enterprise Value | 8.7B EUR | 9.28B EUR | 10.07B EUR | 14.4B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -52.3x | -- | -- | -- |
Price to Sales | 140.02x | 174.71x | 183.6x | 616.36x |
Price to Book | 7.09x | 7.39x | 7.35x | 10.26x |
EV/Revenue | 121.71x | 155.36x | 168.05x | 563.2x |
EV/EBITDA | -23.55x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.39% | -1.82% | -1.71% | -0.69% |